Tang Capital Management’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$35.1M	Hold	1,792,626	–	–	1.78%	19
2025 Q4	$55.8M	Sell	1,792,626 -1,050,299	-37%	-$28.8M	2.76%	14
2025 Q3	$61.4M	Hold	2,842,925	–	–	2.36%	9
2025 Q2	$39.7M	Buy	2,842,925 +50,000	+2%	+$679K	2.01%	11
2025 Q1	$37.6M	Buy	2,792,925 +300,000	+12%	+$5.11M	2.08%	11
2024 Q4	$47.8M	Buy	2,492,925 +250,000	+11%	+$5.44M	3.16%	6
2024 Q3	$51M	Buy	2,242,925 +850,000	+61%	+$13.9M	3.65%	4
2024 Q2	$18.1M	Buy	1,392,925 +700,000	+101%	+$9.69M	1.85%	14
2024 Q1	$12.1M	Hold	692,925	–	–	1.26%	26
2023 Q4	$15.1M	Buy	692,925 +23,800	+4%	+$376K	1.39%	21
2023 Q3	$10.3M	Sell	669,125 -23,800	-3%	-$454K	1.45%	23
2023 Q2	$16.5M	Hold	692,925	–	–	2.43%	13
2023 Q1	$17.6M	Hold	692,925	–	–	2.63%	12
2022 Q4	$20.2M	Sell	692,925 -190,000	-22%	-$4.38M	2.94%	11
2022 Q3	$18.1M	Buy	882,925 +482,925	+121%	+$8.68M	2.22%	14
2022 Q2	$4.63M	Buy	+400,000	New	+$5.38M	0.7%	33